These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15562910)

  • 21. Healing of two and three wall intrabony periodontal defects following treatment with an enamel matrix derivative combined with autogenous bone.
    Yilmaz S; Cakar G; Yildirim B; Sculean A
    J Clin Periodontol; 2010 Jun; 37(6):544-50. PubMed ID: 20507378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Bernardi F; Montebugnoli L; De SM
    J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study.
    Lekovic V; Camargo PM; Weinlaender M; Vasilic N; Kenney EB
    J Periodontol; 2002 Feb; 73(2):198-205. PubMed ID: 11895286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
    Döri F; Arweiler N; Gera I; Sculean A
    J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of intrabony defects with an enamel matrix protein derivative or bioabsorbable membrane: an 8-year follow-up split-mouth study.
    Sculean A; Schwarz F; Miliauskaite A; Kiss A; Arweiler N; Becker J; Brecx M
    J Periodontol; 2006 Nov; 77(11):1879-86. PubMed ID: 17076614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of calcium sulfate and autogenous bone graft to bioabsorbable membranes plus autogenous bone graft in the treatment of intrabony periodontal defects: a split-mouth study.
    Orsini M; Orsini G; Benlloch D; Aranda JJ; Lazaro P; Sanz M; De Luca M; Piattelli A
    J Periodontol; 2001 Mar; 72(3):296-302. PubMed ID: 11327056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of intrabony defects with enamel matrix proteins or barrier membranes: results from a multicenter practice-based clinical trial.
    Sanz M; Tonetti MS; Zabalegui I; Sicilia A; Blanco J; Rebelo H; Rasperini G; Merli M; Cortellini P; Suvan JE
    J Periodontol; 2004 May; 75(5):726-33. PubMed ID: 15212355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
    Velasquez-Plata D; Scheyer ET; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
    Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
    J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
    Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
    J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of angular bone defects with a composite bone grafting material in combination with a collagen membrane.
    Zitzmann NU; Rateitschak-Plüss E; Marinello CP
    J Periodontol; 2003 May; 74(5):687-94. PubMed ID: 12816302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between enamel matrix proteins used alone or in combination with bovine porous bone mineral in the treatment of intrabony periodontal defects in humans.
    Lekovic V; Camargo PM; Weinlaender M; Nedic M; Aleksic Z; Kenney EB
    J Periodontol; 2000 Jul; 71(7):1110-6. PubMed ID: 10960017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal repair in intrabony defects treated with a calcium sulfate implant and calcium sulfate barrier.
    Kim CK; Chai JK; Cho KS; Moon IS; Choi SH; Sottosanti JS; Wikesjo UM
    J Periodontol; 1998 Dec; 69(12):1317-24. PubMed ID: 9926761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors influencing the outcome of regenerative therapy in mandibular Class II furcations: Part I.
    Bowers GM; Schallhorn RG; McClain PK; Morrison GM; Morgan R; Reynolds MA
    J Periodontol; 2003 Sep; 74(9):1255-68. PubMed ID: 14584858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enamel matrix proteins and bovine porous bone mineral in the treatment of intrabony defects: a comparative controlled clinical trial.
    Zucchelli G; Amore C; Montebugnoli L; De Sanctis M
    J Periodontol; 2003 Dec; 74(12):1725-35. PubMed ID: 14974812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of interleukin-1 gene polymorphism on periodontal regeneration in intrabony defects.
    Christgau M; Aslanidis C; Felden A; Hiller KA; Schmitz G; Schmalz G
    J Periodontal Res; 2003 Feb; 38(1):20-7. PubMed ID: 12558933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enamel matrix derivative versus bioactive ceramic filler in the treatment of intrabony defects: 12-month results.
    Leknes KN; Andersen KM; Bøe OE; Skavland RJ; Albandar JM
    J Periodontol; 2009 Feb; 80(2):219-27. PubMed ID: 19186961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone replacement grafts for the treatment of periodontal intrabony defects.
    Hanes PJ
    Oral Maxillofac Surg Clin North Am; 2007 Nov; 19(4):499-512, vi. PubMed ID: 18088901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
    Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
    J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of smoking on long-term clinical results of intrabony defects treated with regenerative therapy.
    Rosen PS; Marks MH; Reynolds MA
    J Periodontol; 1996 Nov; 67(11):1159-63. PubMed ID: 8959564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.